PHVS

PHVS

USD

Pharvaris N.V. Ordinary Shares

$21.640-0.842 (-3.746%)

实时价格

Healthcare
生物技术
瑞士

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$22.482

最高价

$22.482

最低价

$21.585

成交量

0.14M

公司基本面

市值

1.4B

所属行业

生物技术

国家/地区

Switzerland

交易统计

平均成交量

0.19M

交易所

NMS

货币

USD

52周价格范围

最低价 $11.51当前价 $21.640最高价 $26.33

相关新闻

GlobeNewswire

Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting

ZUG, Switzerland, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living

查看更多
Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60

HC Wainwright & Co. analyst Patrick R. Trucchio initiates coverage on Pharvaris with a Buy rating and announces Price Target of $60.

查看更多
HC Wainwright & Co. Initiates Coverage On Pharvaris with Buy Rating, Announces Price Target of $60
Analyst Upgrades

B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27

B of A Securities analyst Tazeen Ahmad upgrades Pharvaris from Underperform to Neutral and raises the price target from $16 to $27.

查看更多
B of A Securities Upgrades Pharvaris to Neutral, Raises Price Target to $27